The WHO estimates that 422 million people worldwide suffer from diabetes, with the majority residing in low- or middle-income ...

New research from Washington State University in collaboration with five other institutions suggests that automated insulin ...

The US Food and Drug Administration approved the first-ever rapid-acting insulin for reducing blood sugar levels. It calls ...

During a hearing, representatives for the Newsom administration said they could not provide a timeline for when ...

Ozempic (semaglutide) is prescribed to treat type 2 diabetes mellitus ... Ozempic is a brand-name, glucagon-like peptide-1 (GLP-1) receptor agonist. It's available in a prefilled pen to inject the ...

As the name suggests, cystic fibrosis-related diabetes is unique to people with CF and ... and additional supplies such as continuous glucose monitors, test strips, insulin pens, syringes or needles, ...

The global Smart Insulin Pens Market is experiencing substantial growth, driven by the increasing prevalence of diabetes, advancements in digital healthcare solutions, and the demand for user-friendly ...

A lack of adequate insulin plays a key role in the development of diabetes. Hormones are chemical messengers that instruct specific cells or tissues to act to support a particular function in the ...

The development of AI-powered smart insulin pens with machine learning algorithms is transforming diabetes management. Features such as automated dose reminders, real-time glucose monitoring ...

including all with type 1 diabetes who use multiple daily injections rather than a pump. And because pharmacies can’t break up boxes containing five insulin pens, patients can also be charged ...

The state-of-the-art facility, established through a collaboration between Sanofi, Sudair Pharma Company (SPC), and NUPCO, aims to enhance national drug security and improve access to life-saving ...